Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

NSCLC treatment

Nov 29, 2024

Evaluating Key Advancements and Emerging Therapies in EGFR-Non Small Cell Lung Cancer Treatment Market

Nov 29, 2024

The Next Chapter in NSCLC Treatment Space: Recent Discoveries and Innovations

Jan 08, 2024

Unlocking New Avenues in KRAS-Driven Cancer Research Beyond G12C

Sep 08, 2023

A Quick Review of Antibody-Drug Conjugates (ADCs) in Lung Cancer: HER2, TROP-2, HER3, MET, and CEACAM5 ADC Advancements

Mar 17, 2023

Immuno-Oncology (I-O) Therapeutics: The Key to Future Cancer Treatment

Nov 25, 2022

ESMO Asia 2022: Role of EGFR and ALK mutations in the East Asian Lung Cancer Market

Jan 14, 2022

Most Promising Oncological Drugs Expected to Launch in 2022

Newsletter/Whitepaper